Jeanie Herbert | Senior Director, IR & Corporate Communications |
Daniel Browne | Co-Founder, President, CEO & Director |
Tobin Schilke | CFO & Principal Accounting Officer |
Dustin Sjuts | Head, Commercial, Aesthetics & Therapeutics |
Abhay Joshi | COO |
Seamus Fernandez | Guggenheim Securities |
Annabel Samimy | Stifel, Nicolaus & Company |
Kenneth Cacciatore | Cowen and Company |
David Amsellem | Piper Jaffray Companies |
Douglas Tsao | H.C. Wainwright & Co. |
Myles Minter | William Blair & Company |
Alexander Lim | Mizuho Americas |
Welcome to the Revance Therapeutics First Quarter 2019 Financial Results and Corporate Update Conference Call. [Operator Instructions].
As a reminder, this call is being recorded today, May 8, 2019. I would now like to turn the conference call over to Jeanie Herbert, Senior Director of Investor Relations and Corporate Communications for Revance. Please go ahead.